Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.039 USD | -3.09% | -1.58% | +7.21% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.21% | 28.24M | |
+2.18% | 42.75B | |
+47.81% | 41.61B | |
+12.32% | 41.34B | |
-12.36% | 26.59B | |
+8.71% | 25.49B | |
-23.43% | 18.12B | |
+30.90% | 12.24B | |
-1.83% | 11.76B | |
+8.59% | 11B |
- Stock Market
- Equities
- APRE Stock
- News Aprea Therapeutics, Inc.
- Aprea Therapeutics : Granted FDA Orphan Drug Designation for Eprenetapopt to Treat Leukemia; Shares Rise Midday